The available data suggest that
reversal of scopolamine - induced
cognitive impairment is a viable model for predicting pharmacodynamic signals
of cognition enhancing compounds in animals [91].
His group has developed a new approach to the treatment
of Alzheimer's disease, and this approach has led to the discovery
of subtypes
of Alzheimer's disease, followed by the first description
of reversal of symptoms in patients with mild cognitive impairment and early Alzheimer's disease, with the ReCODE (Reversal of Cognitive Decline) p
reversal of symptoms in patients with mild
cognitive impairment and early Alzheimer's disease, with the ReCODE (Reversal of Cognitive Decline)
cognitive impairment and early Alzheimer's disease, with the ReCODE (
Reversal of Cognitive Decline) p
Reversal of Cognitive Decline)
Cognitive Decline) protocol.